Market Place
Sourcing Support
Chroma Medicine Presents Preclinical Data on PCSK9 Epigenetic Editor
03 Sep 2024 //
PR NEWSWIRE
Epigenetic editing startup Chroma lays off staff, focusing on reaching clinic
01 May 2024 //
ENDPTS
Chroma Presents Data Showing Durable Cholesterol Reduction with a PCSK9
11 Nov 2023 //
PR NEWSWIRE
Chroma Medicine Presents Data Showing Specific and Durable HBV Silencing
20 Sep 2023 //
PR NEWSWIRE
Sangamo Therapeutics and Chroma Medicine Announce Option and License Agreement
20 Jul 2023 //
BUSINESSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.